Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer

被引：0
作者：
I. V. Balalaeva
L. V. Krylova
M. A. Karpova
A. A. Shulga
E. V. Konovalova
E. L. Guryev
S. M. Deyev
机构：
[1] Lobachevsky State University of Nizhny Novgorod,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Sechenov First Moscow State Medical University,undefined
来源：
Doklady Biochemistry and Biophysics | 2022年 / 507卷
关键词：
targeted therapy; recombinant anticancer toxin; DARPin-LoPE; photodynamic therapy; photodithazine; breast cancer; HER2 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 333
页数：3
相关论文
共 50 条
  • [21] Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
    Simmons, Christine
    Rayson, Daniel
    Joy, Anil Abraham
    Henning, Jan-Willem
    Lemieux, Julie
    McArthur, Heather
    Card, Paul B.
    Dent, Rebecca
    Brezden-Masley, Christine
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [22] Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
    Du, Jiaqun
    Liu, Xiaobang
    Sun, Junpeng
    Wu, Qian
    Hu, Yu
    Shi, Huan
    Zheng, Li
    Liu, Ying
    Wu, Chao
    Gao, Yu
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [23] Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
    Ferrando-Diez, Angelica
    Felip, Eudald
    Pous, Anna
    Bergamino Sirven, Milana
    Margeli, Mireia
    CANCERS, 2022, 14 (14)
  • [24] Pertuzumab in HER2-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1709 - 1716
  • [25] Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer
    Montagna, Emilia
    Colleoni, Marco
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [26] Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm
    Soberino, Jesus
    Racca, Fabricio
    Perez-Garcia, Jose
    Garcia-Fernandez, Luis F.
    Cortes, Javier
    CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 248 - 258
  • [27] The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer
    Cai, Wenbin
    Lv, Wei
    Meng, Li
    Duan, Yunyou
    Zhang, Li
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 339 - 351
  • [28] Targeted multimodal synergistic therapy of drug-resistant HER2-positive breast cancer by pyrotinib-ICG self-assembled nanoparticles
    Xuhong, Juncheng
    Wu, Nisha
    Shi, Qiyun
    Tian, Hao
    Peng, Zaihui
    Jiang, Jun
    Zhang, Jing
    Qi, Xiaowei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (08):
  • [29] Systemic therapy for HER2-positive early-stage breast cancer
    Mathew, Aju
    Romond, Edward H.
    CURRENT PROBLEMS IN CANCER, 2016, 40 (2-4) : 106 - 116
  • [30] Current challenges in HER2-positive breast cancer
    Puglisi, Fabio
    Fontanella, Caterina
    Amoroso, Vito
    Bianchi, Giulia Valeria
    Bisagni, Giancarlo
    Falci, Cristina
    Fontana, Andrea
    Generali, Daniele
    Gianni, Lorenzo
    Grassadonia, Antonio
    Moscetti, Luca
    Portarena, Ilaria
    Rossi, Emanuela
    Marchetti, Paolo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 211 - 221
12345